MS has been reported to affect more than 2 million people worldwide and is considered the most common non-traumatic cause of disability in young adults. Current therapies for multiple sclerosis effectively reduce inflammation, but do little in terms of repair to the damaged central nervous system. Treatment modalities include use of immunosuppressants, beta interferon and monoclonal antibodies.
Cellular therapy might be effective through multiple mechanisms including neuroprotection, immunomodulation and neuroregeneration. It is also possible that these cells may differentiate into neural cells and contribute to cell replacement. The purpose of cellular therapy for MS is to slow the progression of the disease, minimize symptoms during exacerbations and to improve physical and mental functions.
Our protocol involves harvesting cells from the patients own body (autologous stem cells). After activation the cells are transplanted into the appropriate site. The degree of improvement achieved will depend on the stage of the condition, presence of other influencing factors and patient compliance with respect to following diet and allied therapies (physiotherapy, yoga).